{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/0173-0873#drug","name":"Incruse Ellipta","alternateName":"umeclidinium","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"0173-0873"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"NDA205382"}],"activeIngredient":"UMECLIDINIUM BROMIDE","administrationRoute":["ORAL"],"dosageForm":"AEROSOL, POWDER","manufacturer":{"@type":"Organization","name":"GlaxoSmithKline LLC"},"drugClass":[],"isAvailableGenerically":false,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/NDA205382","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0173-0873"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-12T23:21:08.127Z"}}